n-acetyl-beta-glucosaminyl-n-acetylmuramyl-alanylisoglutamine and Malaria

n-acetyl-beta-glucosaminyl-n-acetylmuramyl-alanylisoglutamine has been researched along with Malaria* in 1 studies

Other Studies

1 other study(ies) available for n-acetyl-beta-glucosaminyl-n-acetylmuramyl-alanylisoglutamine and Malaria

ArticleYear
Nor-MDP, saponin, corynebacteria, and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques.
    Bulletin of the World Health Organization, 1979, Volume: 57 Suppl 1

    Vaccination of primates against malaria using antigen derived from erythrocytic parasite stages has been most successful where Freund's complete adjuvant has been employed. Since this adjuvant is clinically unacceptable its replacement is a matter of urgency.In the present work a muramyldipeptide derivative (nor-MDP) given in mineral oil has proved to be partially effective as an adjuvant for merozoite vaccination of Macaca mulatta against Plasmodium knowlesi, and saponin has proved to be effective in similar vaccination of M. fascicularis.

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Bordetella pertussis; Glycopeptides; Haplorhini; Macaca fascicularis; Macaca mulatta; Malaria; Propionibacterium acnes; Saponins; Vaccination

1979